ESC 2021: Recommendations From Dr. James Udelson
Friday, August 27, 2021; 11:25 AM–11:55 AM
Hot Line
GUIDE-HF: haemodynamic-guided management of heart failure – randomised arm primary outcomes. J Lindenfeld
Friday, August 27, 2021; 11:55 AM–12:40 PM
Hot Line
EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes. S Anker
EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis. M Packer
Friday, August 27, 2021; 4:30 PM–5:15 PM
Late-Breaking Science
AVANTI: Dual VP-receptor Antagonism in HF. JE Udelson
Saturday, August 28, 2021; 11:25 AM–12:10 PM
Hot Line
FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes. B Pitt
FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes. G Filippatos
Sunday, August 29, 2021; 4:30–5:15
Late-Breaking Science
The PACIFIC-II study: Diagnostic Comparison of SPECT, PET and MRI in Patients with Prior CAD. PA Van Diemen
Click on any of these tags to subscribe to Topic Alerts. Once subscribed, you can get a single, daily email any time PracticeUpdate publishes content on the topics that interest you.
Visit your Preferences and Settings section to Manage All Topic Alerts
Additional Info
Disclosure statements are available on the authors' profiles: